-
May 21, 2013
Elan seems to be set on wasting the Tysabri windfall instead of returning it to shareholders
-
May 09, 2013
More questions about the real efficacy of fish oil is bad news for Amarin.
-
May 08, 2013
Amgen really needs the pipeline to come through to support this valuation.
-
April 17, 2013
Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
-
February 14, 2013
OncoGenex Pharmaceuticals, Inc. (OGXI) recently announced that it is looking to move its oncology candidate, ...
-
February 14, 2013
Mylan (MYL) extended its three-year old partnership with India-based Biocon Limited. The companies recently signed a ...
-
February 14, 2013
Acorda Therapeutics Inc.'s (ACOR) fourth quarter earnings (including share-based compensation charges but excluding ...
-
February 14, 2013
Hospira Inc.'s (HSP) fourth quarter 2012 earnings (excluding special items) of 55 cents per share beat the Zacks ...
-
February 12, 2013
Regeneron Pharmaceuticals, Inc. (REGN) recently announced that it has received a notification under the ...
-
February 12, 2013
Cardiome Pharma Corp. (CRME) recently selected privately-held Quintiles for providing lifecycle safety and global ...
-
February 12, 2013
Shire plc (SHPG) recently announced that the company has initiated a phase III study to evaluate the efficacy and ...
-
February 11, 2013
Acorda Therapeutics, Inc. (ACOR) recently announced that data from preclinical studies evaluating glial growth ...
-
February 11, 2013
Novo Nordisk (NVO) recently faced a setback when the US Food and Drug Administration (FDA) declined to approve its ...
-
February 11, 2013
Eli Lilly and Company (LLY) recently provided an update on its rheumatoid arthritis candidate, tabalumab. The ...
-
February 08, 2013
Myriad Genetics Inc. (MYGN) reported EPS of 42 cents in the second quarter of fiscal 2013, representing a beat of ...
-
February 08, 2013
Sanofi (SNY) reported fourth quarter 2012 business earnings of 77 cents per American Depository Share (ADS), in line ...
-
February 08, 2013
Teva Pharmaceutical Industries (TEVA) reported fourth quarter earnings of $1.32 per American Depositary Share (ADS), ...
-
February 07, 2013
Recently, Sanofi (SNY) received encouraging news with the European Commission (EC) approving its diabetes candidate, ...
-
February 07, 2013
Pfizer Inc. (PFE) recently received a favorable ruling in its patent infringement case against Actavis, Inc. (ACT) ...
-
February 07, 2013
GlaxoSmithKline (GSK) reported fourth quarter earnings of 57 cents per ADS, missing the Zacks Consensus Estimate of ...
